Description
Rapaflo, the brand name for silodosin, is a medication prescribed to treat the symptoms of benign prostatic hyperplasia (BPH), also known as an enlarged prostate. Rapaflo belongs to a class of drugs known as alpha-blockers, which work by relaxing the muscles in the bladder, neck, and prostate, making it easier to urinate. This improved urine flow can help alleviate some of the symptoms associated with BPH, such as difficulty in starting urination, weak stream, and the need to urinate frequently or urgently.